| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16f935ea6cb9c8927f7e3255aa283c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba045776bcd32d32e3100da8dfce4e28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
1992-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d5e3844204cb9cff46f0bfe4a594f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfcdc75d8128c64076cc30e6894db857 |
| publicationDate |
1994-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0580632-A1 |
| titleOfInvention |
Antibiotic carbapenem derivatives |
| abstract |
The invention relates to a compound of formula (I) wherein R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; n is zero or an integer from 1 to 4; and P represents a benzene ring substituted by the groups R3 and R4 which are ortho to each other, where R3 and R4 are one independently of the other hydroxy or some of their esters which are hydrolysable in vivo; or P is a group of formula (II) or (III), where M represents oxygen or a group NR5 where R5 is hydrogen or C1-4 alkyl; the P ring being optionally still substituted; or a pharmaceutically acceptable salt of these compounds or one of their esters hydrolyzable in vivo. |
| priorityDate |
1991-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |